CAS 501-36-0

Codes: Trans-resveratrol, Resveratrol

Application context (from source-drug indications)

Friedreich's ataxiaTrans-resveratrol (Jupiter Orphan Therapeutics)Parkinson's diseaseTrans-resveratrol (Jupiter Orphan Therapeutics)Alzheimer's diseaseTrans-resveratrol (Jupiter Orphan Therapeutics)DyslipidaemiaResveratrolPeripheral arterial diseaseResveratrolParkinson's diseaseResveratrol口腔扁平苔藓Resveratrol口腔疾病ResveratrolDiabetic neuropathyResveratrol

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Trans-resveratrol (Jupiter Orphan Therapeutics)	Tier C — Watch / trade	-
Resveratrol	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Trans-resveratrol (Jupiter Orphan Therapeutics)Originator routesteps: 1total yield: 160 g (Trans-resveratrol)

Trans-resveratrol→3,5-dihydroxybenzaldehyde→dimethyl (4-hydroxybenzyl)phosphonate

ResveratrolOriginator routesteps: 5total yield: 0.39 g (Resveratrol)

Resveratrol→methyl 3,5-dimethoxybenzoate→methyl 2-(4-methoxyphenyl)acetate→methyl 3-(3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)-3-oxopropanoate→1-(3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)ethan-1-one→1-(3,5-dimethoxyphenyl)-2-(4-methoxyphenyl)ethan-1-ol→(E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.